asimadoline: Clinical Trials

7 trials of asimadoline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 recruiting, 1 terminated. 5 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Recruiting 1, Terminated 1
Phase 11Completed 1
Phase 31Completed 1

Follow asimadoline: new trials by email Literature Review of asimadoline trials Research Report on asimadoline

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).
Asimadoline - Vasomotor Symptoms
Phase 2RecruitingTioga Pharmaceuticals1202025-08-132026-10-08
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
Asimadoline, Placebo - Pruritus, Atopic Dermatitis
Phase 2CompletedTioga Pharmaceuticals2492015-07-012017-12-13
A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers
asimadoline - Healthy
Phase 1CompletedTioga Pharmaceuticals62011-06-012011-10-18
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Asimadoline, Placebo - Diarrhea Predominant Irritable Bowel Syndrome
Phase 3CompletedTioga Pharmaceuticals6112010-05-012013-12-18
Asimadoline for the Treatment of Post-Operative Ileus
Asimadoline, Placebo - Post-Operative Ileus
Phase 2TerminatedTioga Pharmaceuticals352007-01-012012-01-06
Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome
Asimadoline, Placebo - Irritable Bowel Syndrome
Phase 2CompletedTioga Pharmaceuticals5962006-08-012011-10-18
Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome
asimadoline - Irritable Bowel Syndrome
Phase 2CompletedMayo Clinic1002005-01-012011-03-23

Conditions studied

Irritable Bowel Syndrome (2)  ·  Dermatitis, Atopic (1)  ·  Hot Flashes (1)  ·  Pruritus (1)

Sponsors

Tioga Pharmaceuticals (6)  ·  Mayo Clinic (1)

Countries

United States (7)

Top investigators

Allen Mangel, MD, PhD (2)  ·  Allen Mangel, M.D.Ph.D. (1)  ·  Dawn McGuire, MD FAAN (1)  ·  Dr. Philip Leese (1)  ·  Sergey Sikora, VP of Clinical Affairs and COO, PhD (1)